trial

Aquestive Therapeutics Faces Securities Class Action Lawsuit

Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

Aquestive Therapeutics, Inc. is facing a securities class action lawsuit. The lawsuit is related to the company's financial performance and is being led by Rosen, a leading trial counsel. The deadline for investors to secure counsel is May 4.

Latest development

2026 - 04 - 26 | AQST DEADLINE : ROSEN , LEADING TRIAL COUNSEL , Encourages Aquestive Therapeutics , Inc . Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST | NDAQ : AQST

Media Coverage · April 27, 2026

LoginForm Rosen, a leading trial counsel, is encouraging investors in Aquestive Therapeutics, Inc. to seek counsel before a May 4 deadline in a securities class action lawsuit. The lawsuit alleges that Aquestive Therapeutics made false or misleading statements about its business. Investors who purchased Aquestive Therapeutics stock may be eligible for compensation.

newspaper Read article

Key Issues

  • • Aquestive Therapeutics
  • • securities class action
  • • Rosen trial counsel
  • • May 4 deadline
smart_toy Juryvine case summary generated from primary court records. How we verify our work.

update What Changed This Week

1 event
newspaper
Media Coverage 5 hours ago
LoginForm Rosen, a leading trial counsel, is encouraging investors in Aquestive Therapeutics, Inc. to seek counsel before a May 4 deadline in a securities class action lawsuit. The lawsuit alleges that Aquestive Therapeutics made false or m
receipt_long Source (filing) expand_more

2026 - 04 - 26 | AQST DEADLINE : ROSEN , LEADING TRIAL COUNSEL , Encourages Aquestive Therapeutics , Inc . Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST | NDAQ : AQST

Open original open_in_new

Juryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.

Advertisement

Case Timeline

1 event
newspaper
Media Coverage April 27, 2026

2026 - 04 - 26 | AQST DEADLINE : ROSEN , LEADING TRIAL COUNSEL , Encourages Aquestive Therapeutics , Inc . Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST | NDAQ : AQST

LoginForm Rosen, a leading trial counsel, is encouraging investors in Aquestive Therapeutics, Inc. to seek counsel before a May 4 deadline in a securities class action lawsuit. The lawsuit alleges that Aquestive Therapeutics made false or misleading statements about its business. Investors who purchased Aquestive Therapeutics stock may be eligible for compensation.

newspaper Read article open_in_new
Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

3 hours, 5 minutes ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.